David Schull is President and Partner at Russo Partners, where he develops and leads communications programs to help healthcare innovators raise capital, secure partnerships, launch products, and build market credibility.
As a former journalist, he brings a sharp sense of strategy, storytelling, and execution to every client engagement by working closely with executives across biopharma, medtech, diagnostics, and digital health to position their breakthroughs with the audiences that matter most. He serves on the boards of the Rice Biotech Launch Pad, Texas Biotech Task Force, Miami Biotech Collective, and Etiquette on the Runway. He holds a J.D. from the University of Miami and a B.S. in journalism from the University of Colorado.